Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics expanded its partnership with Indica Labs to scale AI-powered digital pathology and support more timely, consistent diagnostic insights....

MIDLAND, Texas--(BUSINESS WIRE)--Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) announced today that it will report third quarter 2026 financial and operating results after the market closes for trading on Wednesday, November 4, 2026. Management will host an earnings conference call on Thursday, November 5, 2026 at 9:00 a.m. Central (10:00 a.m. Eastern). Interested parties are invited to participate on the call by dialing (833) 461-5787 (Conference ID: 727909291...

IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc., a medical device company responsible for the development of the Moda-flx™ Hemodialysis System, has announced a panel discussion entitled “Expanding Choice in Hemodialysis” to be held on Friday, October 23 during the American Society of Nephrology’s Kidney Week 2026 in Denver. Expert panelists will discuss clinical evidence pertaining to hemodiafiltration (HDF) and perspectives for successful integration into kidney care in the United States. “We ar...

TORONTO--(BUSINESS WIRE)--Forge First Asset Management Inc. (« Forge First »), filiale en propriété exclusive de Gestion mondiale d’actifs CI (« GMA CI »), annonce le lancement de séries FNB et de séries couvertes en $ US de ses fonds alternatifs liquides, offrant ainsi aux investisseurs un accès accru à ces stratégies axées sur la recherche d’un équilibre entre la préservation du capital et la croissance à long terme. Le placement initial des parts des séries FNB des fonds est maintenant termi...

TORONTO--(BUSINESS WIRE)--Forge First Asset Management launches ETF and U.S. dollar hedged series of its two liquid alternative funds. The ETF series trade today on the TSX....

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced it will deliver Redwire’s Stalker Uncrewed Aircraft Systems (UAS) in support of the National Guard Bureau’s evolving mission requirements and UAS modernization priorities. The value of the purchase orders was approximately $13.8 million. The long range, Group 2 Stalker UAS will provide National Guard instructors with a highly reliable, modular platform...

TORONTO--(BUSINESS WIRE)--Canada Goose Holdings Inc. (NYSE, TSX: GOOS) plans to announce results for the second quarter of fiscal year 2027, which ended September 27, 2026, before markets open on Thursday, November 5, 2026. The Company will host a conference call and webcast to discuss second quarter fiscal 2027 results at 8:30am ET on Thursday, November 5, 2026. A live webcast of the conference call will be available on the company’s website at http://investor.canadagoose.com. The conference c...

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening diseases, focused on inherited cardiovascular disorders, today announced that the company will attend Chardan’s 10th Annual Healthcare Conference. The company will participate in a panel on Tuesday, October 20, 2026, at 11:30 AM ET and host investor meetings. About Rocket Pharmaceuticals, Inc. Rocket Pha...